Literature DB >> 18818683

Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.

Mark B Consugar1, Wai C Wong, Patrick A Lundquist, Sandro Rossetti, Vickie J Kubly, Denise L Walker, Laureano J Rangel, Richard Aspinwall, W Patrick Niaudet, Seza Ozen, Albert David, Milen Velinov, Eric J Bergstralh, Kyongtae T Bae, Arlene B Chapman, Lisa M Guay-Woodford, Jared J Grantham, Vicente E Torres, Julian R Sampson, Brian D Dawson, Peter C Harris.   

Abstract

Large DNA rearrangements account for about 8% of disease mutations and are more common in duplicated genomic regions, where they are difficult to detect. Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in either PKD1 or PKD2. PKD1 is located in an intrachromosomally duplicated region. A tuberous sclerosis gene, TSC2, lies immediately adjacent to PKD1 and large deletions can result in the PKD1/TSC2 contiguous gene deletion syndrome. To rapidly identify large rearrangements, a multiplex ligation-dependent probe amplification assay was developed employing base-pair differences between PKD1 and the six pseudogenes to generate PKD1-specific probes. All changes in a set of 25 previously defined deletions in PKD1, PKD2 and PKD1/TSC2 were detected by this assay and we also found 14 new mutations at these loci. About 4% of the ADPKD patients in the CRISP study were found to have gross rearrangements, and these accounted for about a third of base-pair mutation negative families. Sensitivity of the assay showed that about 40% of PKD1/TSC contiguous gene deletion syndrome families contained mosaic cases. Characterization of a family found to be mosaic for a PKD1 deletion is discussed here to illustrate family risk and donor selection considerations. Our assay improves detection levels and the reliability of molecular testing of patients with ADPKD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818683      PMCID: PMC2756756          DOI: 10.1038/ki.2008.485

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

Authors:  Frans B L Hogervorst; Petra M Nederlof; Johan J P Gille; Cathal J McElgunn; Maartje Grippeling; Roelof Pruntel; Rein Regnerus; Tibor van Welsem; Resie van Spaendonk; Fred H Menko; Irma Kluijt; Charlotte Dommering; Senno Verhoef; Jan P Schouten; Laura J van't Veer; Gerard Pals
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

2.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

3.  Acrofacial dysostosis in a patient with the TSC2-PKD1 contiguous gene syndrome.

Authors:  J G Dauwerse; K Bouman; A J van Essen; A H van Der Hout; G Kolsters; M H Breuning; D J M Peters
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

4.  Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant.

Authors:  Martin W Laass; Miriam Spiegel; Anna Jauch; Gabriele Hahn; Edgar Rupprecht; Christian Vogelberg; Oliver Bartsch; Angela Huebner
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

5.  Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: absence of hot spots.

Authors:  Piotr Kozlowski; John Bissler; York Pei; David J Kwiatkowski
Journal:  Genomics       Date:  2007-12-03       Impact factor: 5.736

6.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

7.  Large deletion causing the TSC2-PKD1 contiguous gene syndrome without infantile polycystic disease.

Authors:  Y M Smulders; B H J Eussen; S Verhoef; C H Wouters
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

8.  Large deletions in the polycystic kidney disease 1 (PKD1) gene.

Authors:  Yavuz Ariyurek; Irma Lantinga-van Leeuwen; Lia Spruit; David Ravine; Martijn H Breuning; Dorien J M Peters
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

9.  ABCA3 gene mutations in newborns with fatal surfactant deficiency.

Authors:  Sergey Shulenin; Lawrence M Nogee; Tarmo Annilo; Susan E Wert; Jeffrey A Whitsett; Michael Dean
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

10.  The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium.

Authors: 
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

View more
  54 in total

Review 1.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

2.  High-resolution melt as a screening method in autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Grazia Maria Virzì; Alice Bruson; Valentina Corradi; Fiorella Gastaldon; Massimo de Cal; Marta Donà; Dinna N Cruz; Maurizio Clementi; Claudio Ronco
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

3.  Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.

Authors:  Katharina Hopp; Emilie Cornec-Le Gall; Sarah R Senum; Iris B A W Te Paske; Sonam Raj; Sravanthi Lavu; Saurabh Baheti; Marie E Edwards; Charles D Madsen; Christina M Heyer; Albert C M Ong; Kyongtae T Bae; Richard Fatica; Theodore I Steinman; Arlene B Chapman; Berenice Gitomer; Ronald D Perrone; Frederic F Rahbari-Oskoui; Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2019-10-09       Impact factor: 10.612

Review 4.  Molecular diagnostics for autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 5.  Clinical and public health implications of emerging genetic technologies.

Authors:  Anne-Marie Laberge; Wylie Burke
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 6.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

7.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 8.  Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.

Authors:  S Brakemeier; F Bachmann; K Budde
Journal:  Pediatr Nephrol       Date:  2016-09-01       Impact factor: 3.714

9.  The HALT polycystic kidney disease trials: design and implementation.

Authors:  Arlene B Chapman; Vicente E Torres; Ronald D Perrone; Theodore I Steinman; Kyongtae T Bae; J Philip Miller; Dana C Miskulin; Frederic Rahbari Oskoui; Amirali Masoumi; Marie C Hogan; Franz T Winklhofer; William Braun; Paul A Thompson; Catherine M Meyers; Cass Kelleher; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2010-01       Impact factor: 8.237

10.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.